Abacus Medicine invests in pharmaceutical wholesaler Pluripharm Group
The strategic alliance will be an active part of an efficient medicine supply to independent pharmacies and hospitals in the Netherlands
Abacus Medicine has signed an agreement to invest in Dutch wholesaler Pluripharm Group and help strengthen the company’s capital base. Pluripharm is one of only four wholesalers in the Netherlands with a full line of medicines.
The strategic alliance will be an active part of an efficient medicine supply and lays a solid foundation for further development of the services of Pluripharm. Simultaneously, it broadens Abacus Medicine’s presence in the pharmaceutical supply chain in line with the company’s European and global strategy.
Managing Director of Pluripharm a.i. Tjeerd van den Berg says: „With the new strategic alliance, Pluripharm positions itself as an innovative, future-proof company that supports independent pharmacies and hospitals in their pharmaceutical patient care with the smart application of drug data.“
Flemming Wagner, CEO and founder of Abacus Medicine, says: “Abacus Medicine and Pluripharm have been business partners since 2015. With this deal, we are extending our cooperation. In due time we will start exploring the exciting synergies, we have identified. Pluripharm operates from a solid foundation including an established customer network of independent Dutch pharmacies and hospitals, and a highly automated, state-of-the-art warehouse, order picking and distribution centre.”
Following stellar growth in recent years, Pluripharm experienced a difficult 2018 caused by delivery problems due to the implementation of a new ERP system and has now initiated a turnaround program. In 2017, Pluripharm achieved turnover of EUR 480 million.
Abacus Medicine partners with wholesalers, pharmacies and hospitals to improve supply of original medicine in Europe and globally, and has achieved high growth rates over a number of years. The company is headquartered in Copenhagen, Denmark, has 560 employees worldwide, and achieved turnover of EUR 253 million in 2017.
The Pluripharm Group is headquartered in Alkmaar, Holland, which is also the home of Abacus Medicine Holland. The two companies will continue to operate under their current names.
Download press release: Abacus Medicine invests in pharmaceutical wholesaler Pluripharm Group
Wir helfen gerne, also scheuen Sie sich bitte nicht, uns bei Fragen zu kontaktieren. Untenstehend finden Sie unsere Hauptniederlassungen, in denen unsere Mitarbeiter aus ganz Europa arbeiten.
1620 Copenhagen V
Maglódi út 6
Berliner Straße 8
The Leadenhall Building,
122 Leadenhall Street,
London EC3V 4AB
12/14 Rond-Point des Champs-Elysées
Paris 75008, France
I am text block. Click edit button to change this text.